Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Viridian Therapeutics, Inc.
Business Segments
Business Segments
Business Segments
6 metrics
Net loss
Operating Expenses
Other items
Segment research and development expense
Segment selling, general and administrative expense
Total share-based compensation expense